Skip to content

Columbia Ventures Corporation

Creating, Discovering and Enhancing Capital Values

  • Team
  • Philosophy
  • Portfolio
    • Augmented Reality
    • Biomedical
    • Energy
    • Food
    • Hospitality
    • Manufacturing
    • Real Estate Development
    • Robotics
    • Software as a Service
    • Telecommunications
    • Past Investments
  • News
  • Contact
Columbia Ventures Corporation

AbSci aims to tackle the antibody market after raising $12m to scale E. coli-based tech

Read now on BioPharma-Reporter.com • June 20, 2018

Enterobacterias. Gram-negative bacterias escherichia coli, salmonella, klebsiella, legionella, mycobacterium tuberculosis, yersinia pestis, and shigella, proteus, enterobacter, serratia, and citrobacter.
Image: Getty/Bet_Noire)
Like Loading...
Unknown's avatarAuthor Columbia VenturesPosted on June 20, 2018June 21, 2018Categories AbSci, BIOMEDICAL

Post navigation

Previous Previous post: Logicalis research shows 72% of CIOs see corporate extortion and ransomware as biggest security threat
Next Next post: Columbia Pulp ramps up hiring

Recent News

  • Iceland volcano erupts, but there’s no stopping Matorka December 21, 2023
  • Absci and Caltech collaborate to accelerate affordable HIV therapeutic vaccine August 17, 2023
  • Headset firm appoint co-founder as new CEO August 11, 2023
Copyright © Columbia Ventures Corporation. All Rights Reserved.

News by Industry/Company

Search Site

  • Team
  • Philosophy
  • Portfolio
    • Augmented Reality
    • Biomedical
    • Energy
    • Food
    • Hospitality
    • Manufacturing
    • Real Estate Development
    • Robotics
    • Software as a Service
    • Telecommunications
    • Past Investments
  • News
  • Contact
Columbia Ventures Corporation Create a website or blog at WordPress.com
  • Reblog
  • Subscribe Subscribed
    • Columbia Ventures Corporation
    • Already have a WordPress.com account? Log in now.
    • Columbia Ventures Corporation
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...
 

    %d